Amgen Company Description
Amgen is among the biggest of the biotech big'uns. And it's determined to get even bigger. The company uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. Anti-anemia drugs Epogen and Aranesp account for more than one-third of its sales. Enbrel, another leading drug, treats rheumatoid arthritis and is one of the best-selling drugs in this multi-billion-dollar market. The company has a promising drug pipeline and marketing alliances with Hoffmann-La Roche, Japanese brewer and drugmaker Kirin, and other pharmas. Amgen sells its products primarily through wholesale distributors in North America and Europe.
View the Comprehensive Company Description for Amgen
The Company Description provides a historical perspective of Amgen's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Amgen's evolution in the marketplace.
